Fidanacogene elaparvovec is an investigational single-infusion gene therapy proposed for the treatment of hemophilia B.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Fidanacogene elaparvovec is an investigational single-infusion gene therapy proposed for the treatment of hemophilia B.
If you have a Hayes login, click here to view the full report on the Knowledge Center.